AB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Le régime cétogène : efficace contre le cancer ? | Revue médicale suisse |  | 2023 | 300 | 153 | ||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | | 2022 | 290 | 573 | ||
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | | 2021 | 266 | 134 | ||
| Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre | Swiss Medical Weekly | | 2021 | 341 | 180 | ||
| Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes | Scientific Reports | | 2020 | 335 | 355 | ||
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | | 2020 | 357 | 194 | ||
| Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor | Cancer Letters | | 2019 | 1,149 | 503 | ||
| BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients | Breast Cancer Research and Treatment |  | 2019 | 442 | 3 | ||
| Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes | British Journal of Cancer | | 2019 | 388 | 205 | ||
| Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer | Clinical Cancer Research | | 2018 | 530 | 1 | ||
| « Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? | Revue médicale suisse | | 2018 | 641 | 846 | ||
| A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells | Oncotarget | | 2017 | 538 | 248 | ||
| Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging | European radiology | | 2016 | 726 | 74 | ||
| Evaluation de l'utilité du test génomique, 21 gènes, comme outil d'aide à la décision thérapeutique dans les cancers précoces du sein, exprimant les récepteurs aux oestrogènes: une expérience genevoise | | 2015 | 919 | 10 | |||
| Breast cancer in younger women in Switzerland 1996-2009: a longitudinal population-based study | Breast | | 2015 | 584 | 662 | ||
| Isolated tumor cells in sentinel lymph nodes of invasive breast cancer: cell displacement or metastasis? | The breast journal | | 2014 | 701 | 0 | ||
| Concordance between Core Needle Biopsy and Surgical Excision Specimens for Tumour Hormone Receptor Profiling According to the 2011 St. Gallen Classification, in Clinical Practice | The breast journal | | 2013 | 628 | 0 | ||
| Is imaging relevant for treatment choice in early stage cervical uterine cancer? | Surgical oncology | | 2012 | 644 | 0 | ||
| Skin necrosis is a clinical manifestation of low-molecular weight heparin-induced thrombocytopenia | Thrombosis and haemostasis | | 2004 | 43 | 0 |
